Papillary renal cell carcinoma

Common Name(s)

Papillary renal cell carcinoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Papillary renal cell carcinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Papillary renal cell carcinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Papillary renal cell carcinoma" returned 102 free, full-text research articles on human participants. First 3 results:

PD-L1 expression in papillary renal cell carcinoma.
 

Author(s): Takanobu Motoshima, Yoshihiro Komohara, Chaoya Ma, Arni Kusuma Dewi, Hirotsugu Noguchi, Sohsuke Yamada, Toshiyuki Nakayama, Shohei Kitada, Yoshiaki Kawano, Wataru Takahashi, Masaaki Sugimoto, Motohiro Takeya, Naohiro Fujimoto, Yoshinao Oda, Masatoshi Eto

Journal:

 

The immune escape or tolerance of cancer cells is considered to be closely involved in cancer progression. Programmed death-1 (PD-1) is an inhibitory receptor expressed on activating T cells, and several types of cancer cells were found to express PD-1 ligand 1 (PD-L1) and ligand 2 (PD-L2).

Last Updated: 14 Jan 2017

Go To URL
Papillary Renal-Cell Carcinoma.
 

Author(s): W Marston Linehan, Maria J Merino, Christopher J Ricketts

Journal: N. Engl. J. Med.. 2016 May;374(20):1991.

 

Last Updated: 19 May 2016

Go To URL
Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: a case report.
 

Author(s): Takao Kamai, Hideyuki Abe, Kyoko Arai, Satoshi Murakami, Setsu Sakamoto, Yasushi Kaji, Ken-Ichiro Yoshida

Journal:

 

Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an autosomal dominant tumor susceptibility syndrome, and the disease-related gene has been identified as fumarate hydratase (fumarase, FH). HLRCC-associated kidney cancer is an aggressive tumor characterized by early metastasis ...

Last Updated: 17 Mar 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Papillary renal cell carcinoma" returned 4 free, full-text review articles on human participants. First 3 results:

Low enhancing papillary renal cell carcinoma diagnosed by using dual energy computerized tomography: a case report and review of literature.
 

Author(s): Shaheen Alanee, Danuta I Dynda, Patrick Hemmer, Bradley Schwartz

Journal:

 

Papillary renal cell carcinoma (pRCC) is a mixed group of tumors that constitutes about 15-20% of all renal cortical cancers. Strong enhancement on computerized tomography (CT) is a feature of clear cell, but not of pRCC making the differentiation of papillary tumors from benign cysts ...

Last Updated: 6 Jan 2015

Go To URL
Sporadic bilateral synchronous multicentric papillary renal cell carcinoma masquerading as bilateral multifocal pyelonephritis.
 

Author(s): V S Karthikeyan, L N Dorairajan, S Kumar, A R Vijayakumar, A Ramesh, N Ganesh Rajesh, D Halanaik, S Gupta

Journal: Ann R Coll Surg Engl. 2014 Jul;96(5):e7-10.

 

Pyelonephritis is defined as an inflammation of the kidney and renal pelvis. The diagnosis is usually clinical. Acute multifocal bacterial nephritis is a rare form of pyelonephritis that is more severe and sepsis is more common. We report a patient who presented with fever and right-sided ...

Last Updated: 4 Jul 2014

Go To URL
Bilateral papillary renal cell carcinoma and angiomyolipoma in the patients with autosomal dominant polycystic kidney disease: case report of two cases and literature review.
 

Author(s): S Konosu-Fukaya, Y Nakamura, F Fujishima, A Kasajima, Y Takahashi, K Joh, Y Ikeda, N Ioritani, M Watanabe, H Sasano

Journal: Pol J Pathol. 2013 Dec;64(4):303-7.

 

We herein report two rare cases of bilateral renal neoplasms associated with autosomal dominant polycystic kidney disease (ADPKD). Case 1: Bilateral nephrectomy was performed on bilateral renal masses in a 58-year-old man with ADPKD. Case 2: Bilateral nephrectomy was performed on ...

Last Updated: 30 Dec 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma
 

Status: Recruiting

Condition Summary: Papillary Renal Cell Carcinoma

 

Last Updated: 1 Apr 2016

Go to URL
Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
 

Status: Recruiting

Condition Summary: Renal Cell Carcinoma; Hereditary Leiomyomatosis and Renal Cell Cancer; Papillary Renal Cell Carcinoma, Sporadic

 

Last Updated: 24 Jan 2017

Go to URL
A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer
 

Status: Recruiting

Condition Summary: Papillary Renal Cell Carcinoma

 

Last Updated: 24 Jan 2017

Go to URL